|
" Adenosine, cardioprotection and its clinical application. "
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
729783
|
| Doc. No
|
:
|
b549539
|
| Title & Author
|
:
|
Adenosine, cardioprotection and its clinical application.
|
| Publication Statement
|
:
|
[Place of publication not identified]: Springer-Verlag New York, 2013
|
| ISBN
|
:
|
1441987363
|
|
|
:
|
: 9781441987365
|
| Contents
|
:
|
I: Adenosine and Cardioprotection. 1. Adenosine and Cardioprotection; R.M. Mentzer, Jr., R. Lasley. II: Cardioprotection and Mechanisms of Ischemic And Reperfusion Injury. 2. Concept of Cardioprotection Against Myocardial Ischemia; M. Hori. 3. The Late Phase of Preconditioning Against Myocardial Stunning; R. Bolli, et al. 4. Coronary Perfusion as the Major Determinant of Myocardial Contractility in the Heart: Implication for Myocardial Hibernation; M. Kitakaze. 5. Myocardial Protection from Reperfusion Injury with Adenosine; J. Vinten-Johansen, Z.-Q. Zhao. III: Cellular Mechanisms of Cardioprotection in Ischemic Preconditioning. 6. Protein Kinase C - the Key-Enzyme in Ischemic Preconditioning? C. Weinbrenner, J.M. Downey. 7. Adenosine, Cardioprotection and Potential Mechanisms; R. Lasley. 8. Activation of Ecto-5'-Nucleotidase Mediates Cardioprotection in Ischemic Preconditioning: Important Role of Protein Kinase C; M. Kitakaze, et al. 9. Role of Mn-SOD Induction in the Second Window Phenomenon of Preconditioning of Ischemic Hearts; T. Kuzuya, et al. 10. Opioid Receptors, KATP Channels and Ischemic Preconditioning; G.J. Gross, J.E. Schultz. 11. Bradykinin and Preconditioning Against Infarction; T. Miura, et al. 12. Preconditioning in Human Muscle and Myocytes; C.S. Carr, D.M. Yellon. 13. Protein Kinase C and Adenosine Synergistically Activate ATP-Sensitive Potassium Currents: Implications for Ischemic Preconditioning; Y. Liu, et al. IV: Clinical Application of New Strategies to Protect the Ischemic Heart. 14. Adenosine and Myocardial Protection in Humans; R.M. Mentzer, Jr. 15. Clinical Applications of Ischemic Preconditioning; Y. Birnbaum, R.A. Kloner. 16. Clinical Pharmacology of Preconditioning and Adenosinergic Drugs; H. van Belle. 17. Clinical Application of Ischemic Preconditioning by ATP-Sensitive Potassium Channel Opener; N. Arakawa, et al. 18. Potassium Channel Openers and Cardiac Surgery; L.P. Perrault, P. Menasche. 19. Anti-ischemic Effects of the ATP-sensitive Potassium Channel Opener During Coronary Angioplasty; S. Saito, et al. 20. Clinical Impact of Ischemic Preconditioning on Infarct Size and Coronary No-Reflow Phenomenon after Successful Recanalization in the Acute Myocardial Infarction; K. Komamura, et al. Index.
|
| LC Classification
|
:
|
RC685.I6A346 2013
|
| |